Bone-protecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts

Menopause

Volumn 15, Issue 4, 2008, Pages 676-683

  Do, Sun Hee ^a   Lee, Ji Won ^b   Jeong, Wong Il ^c   Chung, Jae Yong ^c   Park, Sang Joon ^c   Hong, Il Hwa ^c   Jeon, Sang Kyung ^c   Lee, In Seon ^b   Jeong, Kyu Shik ^c  

^a Konkuk University   (South Korea)

^b Keimyung University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Osteoblast differentiation; Osteoclast apoptosis; Osteoporosis; Rubus coreanus; Trabecular bone

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; COPPER; ESTROGEN; IRON; MAGNESIUM; MANGANESE; MINERAL; PLANT EXTRACT; POTASSIUM; QUERCETIN; RIBOFLAVIN; RUBUS COREANUS EXTRACT; SAFFLOWER EXTRACT; SODIUM; TANNIN; THIAMINE; UNCLASSIFIED DRUG; VITAMIN D; ZINC; ALKALINE PHOSPHATASE; BONE DENSITY CONSERVATION AGENT; CASPASE 3;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; BONE ATROPHY; BONE METABOLISM; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ESTROGEN DEFICIENCY; FEMALE; FRUIT; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; RAT; ROSACEAE; RUBUS COREANUS; SAFFLOWER; TRABECULAR BONE; UTERUS; ANIMAL; BLOOD; CHEMISTRY; FEMUR; HUMAN; METABOLISM; OSTEOLYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYTOTHERAPY; WISTAR RAT;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CASPASE 3; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR; FRUIT; HUMANS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; ROSACEAE;

EID: 51449105417     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31815bb687     Document Type: Article

References (45)

1. Robey PG. The biochemistry of bone: metabolic bone disease, part I. Endocrinol Metab Clin North Am 1996;18:859-902.
2. Turner RT, Riggs BL, Spelsberg T. Skeletal effects of estrogen. Endocr Rev 1994;15:275-300.
3. Eastell R. Management of osteoporosis due to ovarian failure. Med Pediatr Oncol 2003;41:222-227.
4. Zizic TM. Pharmacologic prevention of osteoporotic fractures. Am Fam Physician 2004;70:1293-1300.
5. Dobnig H. A review of teriparatide and its clinical efficacy in the treatment of osteoporosis. Expert Opin Pharmacother 2004;5:1153-1162.
6. Emkey R. Alendronate and risedronate for the treatment of postmeno-pausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations. Med Genet Med 2004;6:6.
7. Fadanelli ME, Bone HG. Combining bisphosphonates with hormone therapy for postmenopausal osteoporosis. Treat Endocrinol 2004;3:361-369.
8. Lindsay R. Hormones and bone health in postmenopausal women. Endocrine 2004;24:223-230.
9. Koyama N, Kuribayashi K, Seki T, et al. Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit low-density lipoprotein (LDL) oxidation and atherosclerosis in apolipo-protein E-deficient mice. J Agric Food Chem 2006;54:4970-4976.
10. Roh JS, Han JY, Kim JH, Hwang JK. Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis. Biol Pharm Bull 2004;27:1976-1978.
11. Cho SH, Lee HR, Kim TH, Choi SW, Lee WJ, Choi Y. Effects of defatted safflower seed extract and phenolic compounds in diet on plasma and liver lipid in ovariectomized rats fed high-cholesterol diets. J Nutr Sci Vitaminol (Tokyo) 2004;50:32-37.
12. Kim HJ, Bae YC, Park RW, et al. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif Tissue Int 2002;71:88-94.
13. Wang B, Shin X, Li Y, Jia Z. Pentacyclic triterpenoid glycosyl esters from Rubus pileatus. Phytochemistry 1997;46:559-563.
14. Patel AV, Rojas-Vera J, Dacke CG. Therapeutic constituents and actions of Rubus species. Curr Med Chem 2004;11:1501-1512.
15. Kim EJ, Lee YJ, Shin HK, Park JH. Induction of apoptosis by the aqueous extract of Rubus creanum in HT-29 human colon cancer cells. Nutrition 2005;21:1141-1148.
16. Mylnikov SV, Kokko HI, Kärenlampi SO, Oparina TI, Davies HV, Stewart D. Rubus fruit juices affect lipid peroxidation in a Drosophila melanogaster model in vivo. J Agric Food Chem 2005;53: 7728-7733.
17. Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T, Okuda H. Anti-obese action of raspberry ketone. Life Sci 2005;77:194-204.
18. Thiem B, Golliñska O. Antimicrobial activity of Rubus chamaemorus leaves. Fitoterapia 2004;75:93-95.
19. Alanís AD, Calzada F, Cedillo-Rivera R, Meckes M. Antiprotozoal activity of the constituents of Rubus coriifolius. Phytother Res 2003;17:681-682.
20. Park JH, Oh SM, Lim SS, et al. Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. Biochem Biophys Res Commun 2006;351:146-152.
21. Stoner GD, Chen T, Kresty LA, Aziz RM, Reinemann T, Nines R. Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr Cancer 2006;54:33-46.
22. Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8:S549-S555.
23. Price PA, Parthemore JG, Deftos LJ, Nishimoto SK. New biochemical marker for bone metabolism. J Clin Invest 1980;66:878-883.
24. Seibel MJ, Cosman F, Shen V, et al. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993;8:881-889.
25. Seydin S, Kung VT, Daniloff YN, et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993;8:635-641.
26. Robins SP. Collagen crosslinks in metabolic bone disease. Acta Orthop Scand 1995;66:171-175.
27. Hellerstein MK, Neese RA. Mass isotopomer distribution analysis at eight years: theoretical, analytic and experimental considerations. Am J Physiol 1999;276:E1146-E1170.
28. Hammett-Stabler CA. The use of biochemical markers in osteoporosis. Clin Lab Med 2004;24:175-197.
29. Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells. Phytochemistry 2001;56:733-739.
30. Mori Y, Hiraki Y, Shukunami C, et al. Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chon-dromodulin-I and-II. FEBS Lett 1997;406:310-314.
31. Kinto N, Iwamoto M, Enomoto-Iwamoto M, et al. Fibroblasts expressing sonic hedgehog induce osteoblast differentiation and ectopic bone formation. FEBS Lett 1997;404:319-323.
32. Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 1999;96: 3540-3545.
33. Kalu DN. The ovariecotmized rat model of postmenopausal bone loss. Bone Miner 1991;15:175-191.
34. Frost HM, Jee WSS. On the rat model of human osteopenias and osteoporosis. Bone Miner 1992;18:227-236.
35. Martin RB, Chow BD, Lucas PA. Bone marrow fat content in relation to bone re-modeling and serum chemistry in intact and ovariectomized dogs. Calcif Tissue Int 1990;46:189-194.
36. Wronski TJ, Walsh CC, Ignaszewskin LA. Histologic evidence for osteopenia and increased bone turn over in ovariectomized rats. Bone 1986;7:119-123.
37. Nuttall ME, Gimble JM. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 2000;27:177-184.
38. Nuttall ME, Patton AJ, Oliverta DL, Nadeau PD, Gowen ME. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 1998;13:371-382.
39. Ganss B, Kim RH, Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999;10:79-98.
40. Anderson JB, Garner SC. The effects of phytoestrogens on bone. Nutr Res 1997;17:1617-1632.
41. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000;72: 844-852.
42. Kang GH, Chan EJ, Choi SW. Antioxidative activity of phenolic compounds in roasted safflower (Carthamus tinctorius L.) seeds. J Food Sci Nutr 1999;4:221-225.
43. Kotaje S, Sato K, Kim KJ, et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids form rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996;11:88-95.
44. Houssiau F, Dvoglaer JP, Van Damme J, Nagant de Deuxchaines C, Van Snick J. Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-788.
45. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993;342:1012-1016.